Gritstone bio Inc
Change company Symbol lookup
Select an option...
GRTS Gritstone bio Inc
QTWO Q2 Holdings Inc
DNAB Social Capital Suvretta Holdings Corp II
UPST Upstart Holdings Inc
GILT Gilat Satellite Networks Ltd
LAIXY LAIX Inc
SPHD Invesco S&P 500® High Dividend Low Volatility ETF
OXBR Oxbridge Re Holdings Ltd
NVO Novo Nordisk A/S
JNJ Johnson & Johnson
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Gritstone bio, Inc. is a biotechnology company. The Company discover, develop, manufacture and deliver next generation cancer and infectious disease immunotherapy candidates by vaccine vectors, self-amplifying mRNA (samRNA) and chimpanzee adenovirus (ChAd). Its two oncology programs in clinical-stage development are GRANITE, individualized neoantigen-based immunotherapy, and SLATE, an off-the-shelf shared neoantigen-based immunotherapy. The Company has an infectious disease pipeline, which includes two programs in clinical-stage development: CORAL, a second-generation COVID-19 vaccine program that may have pan-coronavirus potential to protect against future coronavirus pandemics, and an HIV therapeutic/cure vaccine candidate that are collaborating on with Gilead Sciences, Inc. The Company’s product candidates include GRT-C907 (ChAd)/R908 (samRNA), GRT- C909 (ChAd)/R910 (samRNA), GRT-C909 (ChAd)/R910 (samRNA), GRT-R914 (samRNA), GRT-R912 (samRNA) and GRT-R918 (samRNA).

Closing Price
$2.57
Day's Change
0.04 (1.58%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.72
Day's Low
2.55
Volume
(Average)
Volume:
511,650

10-day average volume:
561,584
511,650

Health Catalyst Welcomes Chief Medical Officer Dr. Melissa Welch and Chief Population Health Officer and Senior Vice President Dr. Edward Sheen to Leadership Team

8:30 am ET August 8, 2022 (PR Newswire) Print

Health Catalyst, Inc. ("Health Catalyst," NASDAQ: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the addition of Chief Medical Officer Dr. Melissa Welch and Chief Population Health Officer and Senior Vice President Dr. Edward Sheen to the executive leadership team.

https://mma.prnewswire.com/media/1323666/Health_Catalyst_Logo.jpg

Dr. Welch will be the physician voice supporting new and current client growth-driving data-informed healthcare improvements across all areas of the business. Dr. Sheen will lead all value-based care initiatives and help Health Catalyst clients to advance their population health management journeys. Both are fully committed to Health Catalyst's mission to be the catalyst for massive, measurable, data-informed healthcare improvements for all, including vulnerable populations.

"We're thrilled to welcome Dr. Welch and Dr. Sheen to Health Catalyst's executive leadership team," said Health Catalyst CEO Dan Burton. "Their personal, lifelong commitments to the values and principles we espouse at Health Catalyst will energize our teams and further our mission of healthcare transformation. We are deeply grateful for their expertise and unwavering passion for improving healthcare for everyone."

As a primary care trained internist with a background in public health epidemiology and more than 20 years of experience in the private sector, Dr. Welch is uniquely positioned to understand the challenges facing both public and private sectors, drive strategy, and bring thought leadership to all departments of Health Catalyst. She founded Perspectives of Differences Diversity Training and Consultation for Health Professionals and will bring her experience as a diversity and cultural competence trainer to the position as well.

Dr. Welch joined Health Catalyst because her life mission aligns closely with the company's. "My lifelong pursuit has been to find a way to help everyone in healthcare and I believe the way to do that is by having a disciplined approach to data and technology usage that drives value-based care results," said Dr. Welch. "What first attracted me to Health Catalyst was their focus on the immeasurable value of every individual and respect for every single team member's contribution. Combine that with the proven effectiveness of their data and analytics technology, professional services, and care partnerships and I'm excited to see how we can positively transform healthcare for all moving forward."

As a practicing physician, educator, and medical school professor with a background in public policy, business, and public health, Dr. Sheen has worked with healthcare systems and payers in 25 states championing initiatives to accelerate their journey to value-based care, including higher quality care, better patient experience, greater care provider engagement, and lower total costs of care. He has held leadership roles across private, government, non-profit, and academic organizations to improve healthcare systems for patients and providers. He has a long-standing commitment to mentoring and has established programs to support the leadership development of future change agents.

Dr. Sheen was also attracted to Health Catalyst's mission, values, and principles. "My mission is to achieve accessible, equitable, innovative, high-performing, and patient-centered healthcare for all. I'm grateful to be part of a company that shares that mission," said Dr. Sheen. "Health Catalyst has been a national leader in developing meaningful solutions to better serve patients. I'm thrilled to work with this tremendous team to transform care delivery, advance health equity, and lower costs for health systems across the country."

About Health Catalyst

Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform--powered by data from more than 100 million patient records and encompassing trillions of facts--as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.

Media Contact:Tarah Neujahr BryanChief Brand and Communications Officermedia@healthcatalyst.com

https://c212.net/c/img/favicon.png?sn=LA36991&sd=2022-08-08

View original content to download multimedia:https://www.prnewswire.com/news-releases/health-catalyst-welcomes-chief-medical-officer-dr-melissa-welch-and-chief-population-health-officer-and-senior-vice-president-dr-edward-sheen-to-leadership-team-301601065.html

SOURCE Health Catalyst

https://rt.prnewswire.com/rt.gif?NewsItemId=LA36991&Transmission_Id=202208080830PR_NEWS_USPR_____LA36991&DateId=20220808

comtex tracking

COMTEX_411839409/1005/2022-08-08T08:30:07

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.